江苏海岸药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
20
NMPA:20
Drug Approvals
Posaconazole Enteric-coated Tablets
- Product Name
- 泊沙康唑肠溶片
- Approval Number
- 国药准字H20243033
- Approval Date
- Jan 9, 2024
NMPA
Phloroglucinol Injection
- Product Name
- 间苯三酚注射液
- Approval Number
- 国药准字H20234732
- Approval Date
- Dec 29, 2023
NMPA
Sugammadex Sodium Injection
- Product Name
- 舒更葡糖钠注射液
- Approval Number
- 国药准字H20223225
- Approval Date
- Apr 12, 2022
NMPA
Sugammadex Sodium Injection
- Product Name
- 舒更葡糖钠注射液
- Approval Number
- 国药准字H20223224
- Approval Date
- Apr 12, 2022
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20213353
- Approval Date
- May 11, 2021
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found